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ABSTRACT 
Merozoite surface protein 8 (MSP8) has shown promise as a vaccine candidate 
in the Plasmodium yoelii rodent malaria model and has a proposed role in 
merozoite invasion of erythrocytes. However, the temporal expression and 
localisation of MSP8 are unusual for a merozoite antigen. Moreover, in P. 
falciparum the MSP8 gene could be disrupted with no apparent effect on in vitro 
growth. To address the in vivo function of full-length MSP8, we truncated MSP8 
in the rodent parasite P. berghei. PbMSP8 disruptant parasites displayed a 
normal blood-stage growth rate but no increase in reticulocyte preference, a 
phenomenon observed in P. yoelii MSP8 vaccinated mice. Expression levels of 
erythrocyte surface antigens were similar in P. berghei wild-type and PbMSP8-
infected erythrocytes, suggesting that a parasitophorous vacuole function for 
MSP8 does not involve global trafficking of such antigens. These data 
demonstrate that a full-length membrane-associated form of PbMSP8 is not 
essential for blood-stage growth. 
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Merozoite surface protein 8 (MSP8) is a glycosylphosphatidyl inositol (GPI)-
anchored membrane antigen originally identified in Plasmodium yoelii [1] and 
soon after in the human malaria parasite P. falciparum [2]. A distinctive feature of 
this protein is a C-terminal double epidermal growth factor (EGF)-like domain that 
resembles that seen in the dominantly expressed merozoite surface protein, 
MSP1. In MSP1, this double EGF module is considered an important target of 
protective antibodies and as a result has become a component of numerous 
strategies being trialled for efficacy as a blood-stage malaria vaccine [3,4]. The 
MSP8 EGF module is predicted to fold similarly to its MSP1 counterpart and, 
remarkably, using allelic replacement the MSP8 double EGF domains have been 
shown to complement the in vitro blood-stage function of the MSP1 EGFs [5]. 
Hence, MSP8 may also be a target of protective antibodies and indeed it has 
shown considerable promise as a protective immunogen in the P. yoelii rodent 
malaria model system, both alone and in combination with MSP1-based antigens 
[1,6,7]. One interesting facet of these rodent malaria vaccine studies was the 
observation that ‘breakthrough’ parasites appear to have an increased 
preference for reticulocytes [6]. This suggested that MSP8 plays a role in 
merozoite entry of mature erythrocytes and that vaccine escape parasites had an 
altered, MSP8-independent, invasion phenotype. Alternate invasion pathways 
that utilise distinct ligand-receptor combinations are well known, at least in P. 
falciparum [8]. Consistent with a role in merozoite invasion, recombinant P. yoelii 
MSP8 has been shown to bind murine erythrocytes although no difference was 
observed in the binding of reticulocytes or normocytes [9].  
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Despite these data, other observations are inconsistent with a generic role for 
MSP8 in erythrocyte attachment and/or invasion. While early observations 
demonstrated schizont/merozoite expression as expected for a merozoite 
antigen, in addition to expression in other stages of the life cycle [2], more recent 
studies have indicated that P. falciparum MSP8 is expressed predominantly in 
ring-stages where it resides in the parasitophorous vacuole and is probably 
attached to the parasite membrane [10,11]. In this latter study by Drew et al [10], 
no expression of P. falciparum MSP8 was observed in merozoites. Moreover, 
two independent gene knockout studies in P. falciparum have shown that the 
MSP8 gene is not required for seemingly normal blood-stage growth [10,12]. 
Similarly in P. yoelii peak expression appears to occur at an earlier time point 
than would be expected for a merozoite antigen, although here peak expression 
occurs within the trophozoite stages [9].  
To further address the in vivo function of a full-length, membrane associated form 
of MSP8, we targeted the P. berghei MSP8 gene (PlasmoDB identity number 
PB000173.03.0) for disruption and analysed blood-stage phenotypes. Gene 
targeting was performed by double-crossover recombination and was designed 
to result in truncation of the MSP8 gene such that the regions encoding the C-
terminal EGF domains and GPI-anchor signal were deleted (Fig. 1A). In vitro 
cultured blood-stage parasites were transfected with the MSP8 knockout 
plasmid, pB3-MSP8-TR/3’, essentially as described elsewhere [13]. Following an 
initial PCR based screen for integration that detected the expected homologous 
integration-specific PCR products (data not shown), parasites were cloned and a 
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representative cloned line was analysed by Southern blotting using the 5’-
targeting sequence as a probe (Fig. 1B). This analysis showed the expected loss 
of the endogenous hybridising band at 8 Kb and the presence of an integration 
specific species at 5 Kb in the disrupted MSP8 line. No other species were 
observed, demonstrating that integration had proceeded by double crossover 
recombination. Western blotting of parasite extracts with antibodies specific for 
the MSP8 EGF domains (M8 Ab) confirmed the absence of MSP8 in the MSP8 
line, with detection of MSP119 used as a loading control for MSP8 parasite 
extracts  (Fig. 1C). A time course analysis of protein expression also confirmed 
that P. berghei MSP8, like its P. yoelii counterpart, is predominately expressed in 
the trophozoite stage, substantially earlier than schizont-specific antigens such 
as MSP1 (Fig. 1C). MSP8 was also detected in the ring stages and by 
immunofluorescence assay (IFA) it was found to localise to the parasitophorous 
vacuole (PV), where it is possibly anchored to the parasite membrane via its GPI-
anchor, especially given that it co-localises with MSP119 at this time. By schizont 
stages, however, MSP8 was present in the food vacuole (Fig. 1D). The specificity 
of this observed reactivity in Western blots and IFA was confirmed by testing the 
reactivity of the same reagent against the MSP8 disrupted line in parallel and 
under identical conditions to wild-type P. berghei parasites. For merozoites, 
however, weak apical reactivity was observed with the anti-MSP8 antibodies in 
IFA but was indistinguishable in the MSP8 and wild-type lines suggesting these 
antibodies are weakly cross-reactive to another parasite protein (data not 
shown). In P. yoelii, MSP8 appeared to have a surface localisation in the intact 
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schizont although the specificity of this reactivity was not confirmed with a P. 
yoelii MSP8 knockout line [9]. In summary, our results with P. berghei confirm the 
two P. falciparum knockout studies, which show that MSP8 is expressed in the 
ring-stages [10,12] and localises to the PV [10]. While expression may progress 
to later stages in the cycle, our study and that by Drew et al [10] clearly show that 
the vast majority of full-length MSP8 is restricted to the food vacuole in mature 
forms.  
Having confirmed that the MSP8 gene could be disrupted in P. berghei, we 
examined the blood-stage phenotype of the ∆MSP8 parasite line. Wild-type P. 
berghei has a preference for invading reticulocytes [14,15], however, at low 
parasite burdens the majority of P. berghei parasites can be found inside mature 
RBCs, which is reflective of the high normocyte:reticulocyte ratio during the early 
stages of infection (see day 5 time point in Fig. 2A) [15]. As the levels of 
parasitemia increase from day 7 onwards, there is a marked increase in 
circulating reticulocytes in response to the decrease in erythrocyte levels, such 
that by day 11 post-infection reticulocytes account for up to 40% of circulating 
cells (Fig. 2B) [15]. With its preference for reticulocytes, therefore, the 
overwhelming majority of parasites can be found inside reticulocytes in the latter 
stages of infection. A similar finding to the wild-type parent was observed with the 
∆MSP8 parasite line, in that there was no difference in the overall growth rates in 
Balb/c mice, nor was there a significant difference in overall reticulocyte 
preference at any time point, including on day 5 when only normocytes were 
observed (Figs. 2A). In addition, no significance differences in reticulocytosis or 
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haemoglobin levels were detected in mice infected with either parasite line over 
the course of the infection (Fig. 2B). 
Another observation in P. yoelii MSP8 vaccination experiments was the detection 
of transcriptional differences in ‘breakthrough’ parasites in genes encoding 
proteins exported to the RBC cytosol and in some instances probably to the 
surface of infected RBCs [9]. In order to investigate if disruption of MSP8 altered 
the expression of antigens on the surface of infected erythrocytes, we performed 
FACS analysis using antisera raised to wild-type P. berghei parasites on whole, 
unfixed parasite populations. Schizont-stage infected erythrocytes reacted most 
strongly with this reagent as expected since it is at this stage that the expression 
of surface antigens is greatest. However, under a range of conditions and in two 
separate experiments, no difference was seen in the reactivity of the ∆MSP8 and 
parental parasites, suggesting that the levels of surface antigen expression are 
similar (Fig. 2C). Hence, it appears unlikely, in this system at least, that MSP8 is 
a key component of a protein-export trafficking machinery predicted to be present 
in the parasitophorous vacuole of ring-stage parasites and which is responsible 
for the global export of antigens to the erythrocyte surface [16]. 
In summary, we have shown that a full-length membrane-associated form of P. 
berghei MSP8 is not required for merozoite invasion, blood-stage development or 
other aspects of blood-stage survival in Balb/c mice. It should be noted, given the 
design of the targeting vector used to create the MSP8 disruptant line, that it is 
possible that a 35 kDa N-terminal fragment of MSP8 missing the C-terminal EGF 
domains and GPI-anchor is likely to be present in ∆MSP8 parasites, which 
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cannot be detected by the available antibodies raised against P. berghei MSP8. 
We cannot rule out the possibility that this polypeptide performs the same 
function as full-length MSP8. However, such a role for this truncated form seems 
unlikely given the lack of the EGF domains and capacity for membrane 
association, features shared by all Plasmodium MSP8 orthologs. Hence, the 
function of MSP8 remains a mystery. It is possible that its primary role is not in 
the blood stage and so was not revealed in this study, however, there is no 
evidence for strong MSP8 mRNA expression in other life stages in either P. 
falciparum or P. berghei. It is possible that in the rodent system MSP8 plays a 
redundant role in invasion [6,9] although this was not revealed in our study and 
also appears unlikely to be the case of P. falciparum where it is completely 
absent from merozoites [10].  
Although clearly not essential, it is curious that MSP8 is expressed in the blood-
stages in both human and rodent Plasmodium species and that its localisation to 
the ring-stage parasitophorous vacuole is conserved across the species. In P. 
falciparum, MSP8 also resides in detergent-resistant membranes where it 
appears to be present in a larger complex [10,17,18]. An as yet undetermined 
role for MSP8 or the MSP8-associated complex in the parasitophorous vacuole 
remains a possibility, however this study suggests that such a function is unlikely 
to involve a major role in protein trafficking.  
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Figure legends 
Fig. 1. Generation of a P. berghei ANKA line harbouring a truncated MSP8 gene. 
(A) Schematic diagram of the P. berghei MSP8 locus, the transfection vector 
pB3-MSP8-TR/3’ used to disrupt the endogenous MSP8 locus (linearised with 
KpnI and BamHI) and the predicted MSP8 locus after integration that results in a 
truncation immediately prior to the start of the double EGF domains. The 5'- and 
3'- MSP8 targeting regions used to drive integration are indicated by heavy solid 
lines and were generated by PCR amplification of P. berghei genomic DNA using 
the oligonucleotides Pb8-5’F (5'-CGGGGTACCttttcttttattagcccactctctatatattatagg) 
and PB8-5’R (5'-CCGCTCGAGttaaattcgatttttttcaataaaatattctgaaatttttttc) and PB-8 
3’F (5'-GGGATATCgttaatatgcatatattatgttatttgaaactag) and PB-8 3’R (5'-
CGCGGATccatcgttcgaaaaaaacagacaatgtac), respectively. The hsp86 3' UTR is 
represented by a grey box and has been described previously [19]. The expected 
sizes of DNA fragments from wild-type and transgenic parasites resulting from 
digestion with EcoRV (Ev) are shown. The EGF region of P. berghei MSP8 to 
which the antibodies (M8 Ab) were derived is indicated [5]. Tg DHFR-TS, 
selectable marker cassette. (B) Southern blot analysis of digested genomic DNA 
showing homologous integration into the MSP8 gene. Genomic DNA from wild-
type (WT) P. berghei and the MSP8 disrupted line that had been cloned 
(MSP8) were digested with EcoRV and hybridised with the portion of MSP8 
that was used as the 5’-targeting sequence. (C) Western blot analysis of parasite 
extracts harvested from ring (R), early trophozoite (ET), trophozoite (T) and 
schizont (S) stages, using rabbit -MSP8 or rabbit -MSP119 antibodies (-
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PbM19 [19], used to confirm equal loading of parasite extracts in wild-type and 
MSP8 disruptant lines and as a control for timing of expression of a schizont 
specific protein), both diluted 1/1000.  (D) Localisation of MSP8 by IFA. 
Acetone/methanol fixed smears of P. berghei parasites from stages throughout 
the asexual life cycle were incubated with a mixture of rabbit -MSP8 (1:2000) or 
mouse -MSP119 (1:1000) antibodies, followed by incubation with a mixture of 
Alexa-Fluor 488-conjugated -rabbit IgG and Alexa-Fluor 568-conjugated goat 
anti-mouse IgG (both diluted 1:1000). Staining of parasite nuclei was performed 
using DAPI. 
Fig. 2. Truncation of MSP8 in P. berghei does not affect parasite growth, tropism 
or surface antigen expression. (A) Balb/c mice were infected intraperitoneally 
with erythrocytes parasitised with either 106 P. berghei wild-type (WT) or ∆MSP8 
parasites. The total blood parasitemia (top) and the percentage of parasites 
invading reticulocytes (bottom) was determined over the course of the infection 
by thin tail blood smears stained with Giemsa. Shown in the mean  SD 
observed in 8 mice. (B) The percentage of reticulocytes in the circulation, and the 
haemoglobin levels (measured using a HemoCue HB201 DM systems; 
HemoCue Australia) were monitored in the mice from day 3 post-infection. 
Shown in the mean  SD observed in 8 mice. (C) Binding of P. berghei wild-type 
(WT) and ∆MSP8 transgenic parasites to serum from mice unexposed to malaria 
parasites (pre) or from mice made hyperimmune to P. berghei [??????
]. The mouse serum was either diluted 1:20, with secondary goat anti-mouse 
Alexa IgG (488 nm) used at 1:500. Samples were analysed using a FACS 
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Calibur Flow cytometer and Flowjo Software. Data represents the average 
fluorescence intensity obtained from two independent experiments (labelled A 
and B), with all samples tested in duplicate. 
 
 
 
 
 
 
 
